Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

NCT07515027 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

PONV

Interventions

DRUG: Prophylactic administration of dolasetron
OTHER: Electroacupuncture
OTHER: Sham electroacupuncture

Sponsor

Shanghai Chest Hospital